Clinical features and visual prognosis of very late-onset neuromyelitis optica spectrum disorder–related optic neuritis.
Saved in:
| Title: | Clinical features and visual prognosis of very late-onset neuromyelitis optica spectrum disorder–related optic neuritis. |
|---|---|
| Authors: | Yang, Qinglin (AUTHOR), Lai, Chuntao (AUTHOR), Meng, Chao (AUTHOR), Chang, Qinglin (AUTHOR), Wei, Na (AUTHOR), Wang, Jiawei (AUTHOR) |
| Source: | Neurological Sciences. May2024, Vol. 45 Issue 5, p2191-2197. 7p. |
| Subjects: | Neuromyelitis optica, Optic neuritis, Antinuclear factors, Logistic regression analysis |
| Abstract: | Background: Very late-onset neuromyelitis optica spectrum disorder–related optic neuritis is limited to a few case reports. Objective: To investigate the clinical features and visual prognosis of very late-onset neuromyelitis optica spectrum disorder–related optic neuritis. Methods: This study evaluated 22 patients with first-onset optic neuritis and fulfilled the 2015 diagnosis criteria for neuromyelitis optica spectrum disorders. Results: The mean age at optic neuritis onset was 73.91 ± 4.71 (range: 70–82) years with a female predominance (81.8%; ratio: 4.5:1). Antinuclear antibody seropositivity and seronegativity were identified in 12 (55.5%) and 10 (45.5%) patients, respectively. Severe visual loss persisted in 19 (19/42, 45.3%) eyes at the last follow-up. Although patients with antinuclear antibody seropositivity had a significantly higher frequency of attacks (P = 0.015), but they had a longer median time to reach severe visual loss (37 vs. 26 months; log-rank test, P = 0.023). Multivariate logistic regression analysis revealed antinuclear antibody seropositivity (hazard ratio = 4.849, 95% confidence interval: 1.309–17.965, P = 0.018) as a good predictor of visual acuity improvement. Conclusion: Patients with very late-onset neuromyelitis optica spectrum disorder–related optic neuritis may develop severe optic neuritis, and those with antinuclear antibody seronegativity have a similar clinical presentation but worse outcome than those with seropositivity. [ABSTRACT FROM AUTHOR] |
| Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 176627715 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinical features and visual prognosis of very late-onset neuromyelitis optica spectrum disorder–related optic neuritis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Yang%2C+Qinglin%22">Yang, Qinglin</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lai%2C+Chuntao%22">Lai, Chuntao</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Meng%2C+Chao%22">Meng, Chao</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chang%2C+Qinglin%22">Chang, Qinglin</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wei%2C+Na%22">Wei, Na</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Jiawei%22">Wang, Jiawei</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Neurological+Sciences%22">Neurological Sciences</searchLink>. May2024, Vol. 45 Issue 5, p2191-2197. 7p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Neuromyelitis+optica%22">Neuromyelitis optica</searchLink><br /><searchLink fieldCode="DE" term="%22Optic+neuritis%22">Optic neuritis</searchLink><br /><searchLink fieldCode="DE" term="%22Antinuclear+factors%22">Antinuclear factors</searchLink><br /><searchLink fieldCode="DE" term="%22Logistic+regression+analysis%22">Logistic regression analysis</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Background: Very late-onset neuromyelitis optica spectrum disorder–related optic neuritis is limited to a few case reports. Objective: To investigate the clinical features and visual prognosis of very late-onset neuromyelitis optica spectrum disorder–related optic neuritis. Methods: This study evaluated 22 patients with first-onset optic neuritis and fulfilled the 2015 diagnosis criteria for neuromyelitis optica spectrum disorders. Results: The mean age at optic neuritis onset was 73.91 ± 4.71 (range: 70–82) years with a female predominance (81.8%; ratio: 4.5:1). Antinuclear antibody seropositivity and seronegativity were identified in 12 (55.5%) and 10 (45.5%) patients, respectively. Severe visual loss persisted in 19 (19/42, 45.3%) eyes at the last follow-up. Although patients with antinuclear antibody seropositivity had a significantly higher frequency of attacks (P = 0.015), but they had a longer median time to reach severe visual loss (37 vs. 26 months; log-rank test, P = 0.023). Multivariate logistic regression analysis revealed antinuclear antibody seropositivity (hazard ratio = 4.849, 95% confidence interval: 1.309–17.965, P = 0.018) as a good predictor of visual acuity improvement. Conclusion: Patients with very late-onset neuromyelitis optica spectrum disorder–related optic neuritis may develop severe optic neuritis, and those with antinuclear antibody seronegativity have a similar clinical presentation but worse outcome than those with seropositivity. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=176627715 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s10072-023-07187-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 7 StartPage: 2191 Subjects: – SubjectFull: Neuromyelitis optica Type: general – SubjectFull: Optic neuritis Type: general – SubjectFull: Antinuclear factors Type: general – SubjectFull: Logistic regression analysis Type: general Titles: – TitleFull: Clinical features and visual prognosis of very late-onset neuromyelitis optica spectrum disorder–related optic neuritis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yang, Qinglin – PersonEntity: Name: NameFull: Lai, Chuntao – PersonEntity: Name: NameFull: Meng, Chao – PersonEntity: Name: NameFull: Chang, Qinglin – PersonEntity: Name: NameFull: Wei, Na – PersonEntity: Name: NameFull: Wang, Jiawei IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: May2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 15901874 Numbering: – Type: volume Value: 45 – Type: issue Value: 5 Titles: – TitleFull: Neurological Sciences Type: main |
| ResultId | 1 |